Article may be outdated

This article is 80 days old. Some details may have changed since publication.

Nature·4 min read·hard

Fluorine-19 MRI signal phenotype in solid tumor following in situ perfluorocarbon cell labeling

Fluorine-19 MRI signal phenotype in solid tumor following in situ perfluorocarbon cell labeling
AI Summary

Researchers have validated the use of fluorine-19 MRI and perfluorocarbon nanoemulsions to track myeloid-lineage immune cells in tumors. This noninvasive imaging technique allows for the quantification of tumor-associated macrophages, which are linked to cancer progression and immunotherapy resistance.

Why it matters

This provides a new, noninvasive biomarker for monitoring tumor microenvironments, potentially improving the efficacy of cancer immunotherapies.

Dive DeeperCreate a free account to unlock

Scientific Reports ( 2026 ) Cite this article

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%

Scientific reporting on medical research methodology.

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in